Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2009
12/03/2009US20090299127 Magnet-Field Controlled Active Substance Transfer for Aerosol Therapy
12/03/2009US20090299066 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
12/03/2009US20090298917 Non-Viral Vector System For The Delivery Of Nucleic Acid Into The Lung
12/03/2009US20090298875 A Combination of Compounds, Which Can be Used in the Treatment of Respiratory Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma
12/03/2009US20090298856 2,3 Substituted fused bicyclic pyrimidin-4(3H)-ones modulating the function of the vanilliod-1receptor (VR1)
12/03/2009US20090298825 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
12/03/2009US20090298824 Organic compounds
12/03/2009US20090298810 IL-8 Receptor Antagonists
12/03/2009US20090298802 Pharmaceutical Compositions
12/03/2009US20090298747 Methods and Compositions For Treatment of Nitric Oxide-Induced Clinical Conditions
12/03/2009US20090297611 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease
12/03/2009US20090297535 Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
12/03/2009CA2725545A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
12/02/2009EP2128163A1 Spiro-ring compound
12/02/2009EP2128125A1 Caffeoyl quinic acid derivatives containing nitrogen, and preparation method, pharmaceutically composition and usage thereof
12/02/2009EP2125841A1 Monophosphates as mutual prodrugs of anti-inflammatory signal transduction modulators (aistm's) and beta-agonists for the treatment of pulmonary inflammation and bronchoconstriction
12/02/2009EP2125804A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoý4,5-b¨pyridin-2-one derivatives useful as a2b adenosine receptor antagonists
12/02/2009EP2125787A1 Derivatives of n-(heteroaryl)-1-heteroaryl-1h-indol-2-carboxamids, preparation thereof and therapeutic use thereof
12/02/2009EP2125744A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
12/02/2009EP2125731A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
12/02/2009EP2125728A1 Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
12/02/2009EP2125722A2 Bi-aryl or aryl-heteroaryl substituted indoles
12/02/2009EP2125714A1 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide
12/02/2009EP2124951A1 5-cyan0-4- (pyrrolo ý2, 3b¨pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
12/02/2009EP2124943A1 Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
12/02/2009EP2124926A1 Treatment for respiratory disease
12/02/2009EP1856093B1 (2R,4aR,10bR)-6-(2,6-dimethoxypyridin-3-yl)-9-ethoxy-8-methoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol, HCl salt
12/02/2009EP1622875B1 Crystalline forms of an arylaniline beta-2 adrenergic receptor agonist
12/02/2009EP1551802B1 Indole-3-sulphur derivatives
12/02/2009EP1434765B1 Substituted piperidines with selective binding to histamine h3-receptor
12/02/2009EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
12/02/2009EP1248804B2 Recombinant antibodies to human interleukin-1 beta
12/02/2009CN101594871A Pyrrolopyrimidine compounds and their uses
12/02/2009CN101590224A High-efficiency 14-valent pneumococcal conjugate vaccine
12/02/2009CN101590215A Traditional Chinese medicine for treating children respiratory repeated infection
12/02/2009CN101590198A Traditional Chinese medicine formulation for curing cough of various types
12/02/2009CN101590196A Chinese medicinal composition for clearing heat and releasing toxin, and dispelling damp heat
12/02/2009CN101590187A Chinese medicinal capsule for treating prosopantritis, ethmoiditis and genyantritis
12/02/2009CN101590179A Chinese medicament for treating pharyngitis
12/02/2009CN101590165A Traditional Chinese medicine for treating pediatric cough
12/02/2009CN101590160A Traditional Chinese medicine for treating cold cough in children
12/02/2009CN101590151A Chinese medicament for curing bone covering tumor
12/02/2009CN101590148A Chewing gum for preventing common cold
12/02/2009CN101590138A Cinnamon Indian buead capsule
12/02/2009CN101590137A Chinese medicament for treating chronic rhinitis
12/02/2009CN101590107A Rhinitis ointment
12/02/2009CN101590074A Application of carbomer gel in prevention of allergic rhinitis
12/02/2009CN101590070A Use of baicalin in preparation of targeted organ protection medicaments
12/02/2009CN101590050A Medicine for treating allergic rhinitis and preparation method thereof
12/02/2009CN101590043A Compound preparation for treating respiratory tract infection and preparation method thereof
12/02/2009CN101590041A Pharmaceutical composition for relieving cough
12/02/2009CN101590035A Application of dehydrogenated silybin in preparing anti-lung-cancer medicament
12/02/2009CN101590033A Medicinal composition fat emulsion injection containing eucalyptol, limonene and alpha-pinene and preparation method
12/02/2009CN101590028A Tulobuterol-containing aquogel patch and preparation method thereof
12/02/2009CN101590022A Theophylline sodium glycinate slow-release tablet and preparation method thereof
12/02/2009CN101590019A Soluble compound doxycycline hyclate powder for animals and preparation method thereof
12/02/2009CN101590009A Novel preparation of tilmicosin and salt of same for livestock and preparation method thereof
12/02/2009CN100564358C Method for making 4-(3,4-dichlorophenoxy)piperidine
12/02/2009CN100563695C Powder medicine for treating throat diseases
12/02/2009CN100563693C Oral Chinese medicine composition for treating chronic bronchitis
12/02/2009CN100563670C Chinese-medicinal composition for treating cough asthma
12/02/2009CN100563667C Medicine for treating tracheitis and rheumatic arthritis
12/02/2009CN100563655C Compositions for treating infection in cattle and swine and its uses
12/02/2009CN100563641C Composition of ambroxol, salt thereof and anti-infective drug
12/01/2009US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009US7625934 Metalloproteinase inhibitors
12/01/2009US7625925 Pyrazolo[1,5-a]pyridines and medicines containing the same
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625904 Methods for the treatment of sleep disorders
12/01/2009US7625887 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma
12/01/2009US7625883 Choline Salt of L- alpha -glycero-phospho-D-mio-inositol; alpha -glycero-phospho-D-mio-inositol tetrabutylammonium salt; treatment of pathologies mediated by the activation or over stimulation of cytololilc phospholipase-2 (PLA2), particularly, septic shock and viral and bacterial infections
12/01/2009US7625881 3-ethyl-2,6-dioxo-1-propyl-8-(1-{[3-(trifluoromethyl)phenyl]methyl}pyrazol-4-yl)-1,3,7-trihydropurin-7-yl]methyl butanoate; treatment of asthma and diarrhea
12/01/2009US7625859 HER-2 binding antagonists
12/01/2009CA2492196C Sulfotransferase inhibitors
12/01/2009CA2461100C 4-imidazolin-2-one compounds
12/01/2009CA2432121C Nitric oxide synthase inhibitor phosphate salt
12/01/2009CA2389412C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/01/2009CA2208503C Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
11/2009
11/26/2009WO2009143483A2 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION
11/26/2009WO2009143292A2 Method of treating pneumoconiosis with oligodeoxynucleotides
11/26/2009WO2009143064A2 Rice bran extracts for inflammation and methods of use thereof
11/26/2009WO2009142589A1 Combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist
11/26/2009WO2009142588A1 Combination of (a) a chemokine receptor 1 (ccr1) antagonist and (b) glucocorticoid receptor modulator
11/26/2009WO2009142571A1 Phenyl and benzodioxinyl substituted indazoles derivatives
11/26/2009WO2009142569A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009WO2009142568A1 Combination of (a) glucocorticoid receptor modulator and (b) a b2-agonist
11/26/2009WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009WO2009142195A1 Agent for induction/maintenance of remission
11/26/2009WO2009141524A1 Method for obtaining an extract of cranberry marc that can be used in particular in the prevention and treatment of conditions such as caries, gingivitis or sore throats
11/26/2009WO2009140984A1 Anhydrous and hydrate forms of crystalline 2- ( (2s, 3r, 4e, 6e, 1oe, 12s) -13- (4-fluorophenoxy) -2,3, 12- (trihydroxytrideca-4, 6, 10-trien-8-ynyl) oxy) acetic acid
11/26/2009WO2009140863A1 Compositions comprising quinazoline derivatives, preparation methods and uses thereof
11/26/2009WO2009113810A3 Pharmaceutical composition, use thereof, and method for the treatment or prevention of allergic and autoimmune diseases
11/26/2009WO2009043458A3 Use of oxytocin to treat many diseases
11/26/2009WO2009043457A3 Use of human hemokinin-1 and optionally oxytocin to treat diseases involving excessive angiogenesis
11/26/2009WO2009040024A3 Use of bim-23127 and optionally urodilatin as therapeutic agents eg for the treatment of m. tuberculosis infections
11/26/2009WO2009039981A3 Use of (arg 8) vasopressin to treat eg s. pneumoniae infection
11/26/2009WO2009039980A3 Use of bfgf 1-24 and optionally (arg 8) vasopressin to treat eg s. pneumoniae infection
11/26/2009WO2009033820A3 Use of saralasin and carbetocin in combination to treat of eg aids or idiopathic pulmonary fibrosis
11/26/2009WO2009033783A3 Use of carbetocin to treat of eg aids or idiopathic pulmonary fibrosis
11/26/2009WO2009033782A3 Use of a teprotide and optionally carbetocin to treat eg aids or idiopathic pulmonay fibrosis
1 ... 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 ... 878